Canada (CA)

Climate impact auctions: an underused tool for green subsidies in the Global South (2025) Matthey MA, Hollis A, Brandi C, Kobiela G, Roth B, Silberberger M Journal article Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedema (2025) Haas Y, Williams OP, Masia J, Pons G, Taylor EM, Katapodi MC, Staub D, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Crash testing machine learning force fields for molecules, materials, and interfaces: model analysis in the TEA Challenge 2023 (2025) Poltavsky I, Charkin-Gorbulin A, Puleva M, Fonseca G, Batatia I, Browning NJ, Chmiela S, et al. Journal article White paper and roadmap for quantum gravity phenomenology in the multi-messenger era (2025) Alves Batista R, Amelino-Camelia G, Boncioli D, Carmona JM, di Matteo A, Gubitosi G, Lobo I, et al. Journal article, Review article IL-4 induces CD22 expression to restrain the effector program of virtual memory T cells (2025) Yang B, Piedfort O, Sanchez-Sanchez G, Lavergne A, Gong M, Peng G, Madrigal A, et al. Journal article Bayesian Uncertainty Estimation Improves nnU-Net Generalization to Unseen Sites for Stroke Lesion Segmentation (2025) Vorberg L, Ditt H, Sühling M, Maier A, Murray N, Nicolaou S, Taubmann O Conference contribution Usefulness of Monoenergetic Non-contrast CT and X-Map Images for Deep Learning-Based Stroke Lesion Segmentation (2025) Vorberg L, Ditt H, Sühling M, Maier A, Murray N, Nicolaou S, Taubmann O Conference contribution Crash testing machine learning force fields for molecules, materials, and interfaces: molecular dynamics in the TEA challenge 2023 (2025) Poltavsky I, Puleva M, Charkin-Gorbulin A, Fonseca G, Batatia I, Browning NJ, Chmiela S, et al. Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article